This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1978 Dec 8;59(3):211-6.

doi: 10.1007/BF00426624.

Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment

J Hyttel

PMID: 32570
DOI: 10.1007/BF00426624

Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment

J Hyttel. Psychopharmacology (Berl). 1978.

. 1978 Dec 8;59(3):211-6.

doi: 10.1007/BF00426624.

Author

J Hyttel

PMID: 32570
DOI: 10.1007/BF00426624

No abstract available

PubMed Disclaimer

Similar articles

Supersensitivity of striatal D2 dopamine receptors mediating inhibition of adenylate cyclase and stimulation of guanosine triphosphatase following chronic administration of haloperidol in mice.
Olianas MC, Onali P. Olianas MC, et al. Neurosci Lett. 1987 Aug 5;78(3):349-54. doi: 10.1016/0304-3940(87)90386-7. Neurosci Lett. 1987. PMID: 2819791
The dopamine receptor adenylate cyclase complex: evidence for post recognition site involvement for the development of supersensitivity.
Parenti M, Gentleman S, Olianas MC, Neff NH. Parenti M, et al. Neurochem Res. 1982 Jan;7(1):115-24. doi: 10.1007/BF00965074. Neurochem Res. 1982. PMID: 7070577
The dopamine D1 receptor: biochemical and behavioral aspects.
Andersen PH, Nielsen EB. Andersen PH, et al. Adv Exp Med Biol. 1986;204:73-91. doi: 10.1007/978-1-4684-5191-7_5. Adv Exp Med Biol. 1986. PMID: 2878580 Review. No abstract available.
Adenosine modulates the dopaminergic function in the nigro-striatal system by interacting with striatal dopamine dependent adenylate cyclase.
Abbracchio MP, Colombo F, Di Luca M, Zaratin P, Cattabeni F. Abbracchio MP, et al. Pharmacol Res Commun. 1987 Apr;19(4):275-86. doi: 10.1016/0031-6989(87)90085-3. Pharmacol Res Commun. 1987. PMID: 2889222
Characterization of dopamine D-1 and D-2 receptors.
Hyttel J, Arnt J. Hyttel J, et al. Adv Exp Med Biol. 1986;204:15-28. doi: 10.1007/978-1-4684-5191-7_2. Adv Exp Med Biol. 1986. PMID: 2878578 Review. No abstract available.

See all similar articles

Cited by

Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
Seeger TF, Thal L, Gardner EL. Seeger TF, et al. Psychopharmacology (Berl). 1982;76(2):182-7. doi: 10.1007/BF00435275. Psychopharmacology (Berl). 1982. PMID: 6805029
Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
Schremmer C, Morgenstern R, Fink H, Ott T. Schremmer C, et al. Psychopharmacology (Berl). 1990;100(3):399-403. doi: 10.1007/BF02244614. Psychopharmacology (Berl). 1990. PMID: 1969173
Dopamine-mediated striatal activity and function is enhanced in GlyRα2 knockout animals.
Devoght J, Comhair J, Morelli G, Rigo JM, D'Hooge R, Touma C, Palme R, Dewachter I, vandeVen M, Harvey RJ, Schiffmann SN, Piccart E, Brône B. Devoght J, et al. iScience. 2023 Jul 17;26(8):107400. doi: 10.1016/j.isci.2023.107400. eCollection 2023 Aug 18. iScience. 2023. PMID: 37554441 Free PMC article.
Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders.
Wesseling H, Guest PC, Lee CM, Wong EH, Rahmoune H, Bahn S. Wesseling H, et al. Mol Autism. 2014 Jul 4;5:38. doi: 10.1186/2040-2392-5-38. eCollection 2014. Mol Autism. 2014. PMID: 25061506 Free PMC article.
In vitro and in vivo disposition of 3H-methiothepin in brain tissues. Relationship to the effects of acute treatment with methiothepin on central serotoninergic receptors.
Nelson DL, Herbet A, Pichat L, Glowinski J, Hamon M. Nelson DL, et al. Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(1):25-33. doi: 10.1007/BF00499871. Naunyn Schmiedebergs Arch Pharmacol. 1979. PMID: 530311

See all "Cited by" articles

References

1. Eur J Pharmacol. 1976 Jul;38(1):197-203 - PubMed
1. Psychopharmacologia. 1974 Jan 11;34(2):111-8 - PubMed
1. Brain Res. 1977 Nov 11;136(2):319-37 - PubMed
1. Mol Pharmacol. 1976 Jul;12(4):639-48 - PubMed
1. Life Sci. 1977 Aug 1;21(3):307-13 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer